周四，UBS对NKT A/S (NKT:DC)启动覆盖，给予卖出评级，目标价为435.00丹麦克朗。该行分析师指出了公司目前正在进行的重大投资阶段（预计持续至2027年）所涉及的多项风险。

UBS initiated coverage on NKT A/S (NKT:DC) with a Sell rating and a price target of DKK435.00. The firm's analyst pointed out several risks associated with the company's ongoing significant investment ...

We confirmed this by IL-13 inhibitor (sIL-13Rα2–Fc) treatment. Loss of natural killer T cells (NKT cells) in CD1 knockout mice resulted in decreased IL-13 production and resistance to recurrence.

Yang及其同事此前报道了一种临床引导培养方法，通过改造人类造血干细胞和祖细胞来产生异体CAR-NKT细胞。作为潜在的应用，本文作者描述了异体cd33靶向CAR-NKT细胞的设计和特性，在骨髓常驻髓系恶性肿瘤的临床前模型中显示出抗肿瘤活性。 新型免疫细胞疗法 ...

Licensing T H or NKT cells cause DCs to produce discrete chemokines that recruit naive CTLs into lymphatic tissues for cross-priming. Also, DC–T H cell interaction in non-lymphatic tissues ...